Home›Companies›Healthcare›O'Ryan Therapeutics

O'Ryan Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Sep 8, 2023·Suggest an edit

About O'Ryan Therapeutics

O'Ryan Therapeutics is a private company based in Wellesley, Massachusetts, incorporated in 2023 in Delaware. It has reported $40,000 raised in one offering on Form D since September 2023. Its chief executive is Michael Parnell.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 29, 2023Sep 8, 2023$40,000of $600K target2$20,000Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on O'Ryan Therapeutics's Form D filed Sep 8, 2023.

TC
Tim Coleman
Executive officer and director
MP
Michael Parnell
President and CEO, director

Sources

  1. SECO'Ryan Therapeutics, Inc. filing history